Researchers in Colorado helped lay the groundwork for a new drug therapy that's offering hope for melanoma patients.
The FDA approved the drug combo last month.
The therapy involved a two drug combination and it blocks different melanoma growth pathways, according to oncologist Karl Lewis of the University of Colorado Cancer Center.
Dr. Karl Lewis says, "We're specifically targeting the cancer cells trying to spare the normal cells and prevent the cancer from growing."
Cancer survivor Dave Brown has been part of the trials.
He says his cancer is now 85 percent gone.